Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Growth Factor Antagonists
Witt, Daniel P.
Repligen Corporation, Waltham, MA, United States
Search 3 grants from Daniel Witt
Search grants from Repligen Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of PDLIM1 in Retinal Vascular Leakage and Proliferation
Crystallographic Structure Determination of Pro Region of A Lytic Protease
Protein Interactions in Herpesvirus Cell Fusion
Grants for Graduate Training in Family Medicine
Symbolic Simulation and Its Application to VLSI System Verification
Recently added grants:
Targeting immune suppressive microenvironment in ATC
Understanding and targeting bone marrow microenvironment in myelofibrosis
Overcoming hypoxic resistance to anti-cancer therapy
Myocardial Radiomics and Mechanics in the Pathology and Prognosis of Cardiovascular Disease
Bio-tribo-corrosion resistant 3D Printed Composites for Load-bearing Implants
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
7R43EY011333-02
Application #
2020035
Study Section
Special Emphasis Panel (ZRG1-VISA (02))
Project Start
1996-03-16
Project End
1997-02-06
Budget Start
1996-03-16
Budget End
1997-02-06
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Repligen Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453
Comments
Be the first to comment on Daniel Witt's grant